share_log

6-K: British American Tobacco p.l.c.8 July 2024Transation In Own Shares

6-K: British American Tobacco p.l.c.8 July 2024Transation In Own Shares

英美菸草公司2024年7月8日以自有股份轉讓
美股sec公告 ·  07/08 16:13
Moomoo AI 已提取核心訊息
British American Tobacco (BAT), the major international tobacco company, has filed a Form 6-K with the United States Securities and Exchange Commission (SEC) on July 8, 2024. The filing, which is a requirement for foreign private issuers in the US, includes a press release titled 'Transaction in own shares' dated the same day. The document was signed by Nancy Jiang, Senior Assistant Company Secretary of BAT. The report indicates that BAT has engaged in a transaction involving its own shares, details of which were made public and available by the company on July 8, 2024. The address of BAT's principal executive office is listed as Globe House, 4 Temple Place, London, United Kingdom.
British American Tobacco (BAT), the major international tobacco company, has filed a Form 6-K with the United States Securities and Exchange Commission (SEC) on July 8, 2024. The filing, which is a requirement for foreign private issuers in the US, includes a press release titled 'Transaction in own shares' dated the same day. The document was signed by Nancy Jiang, Senior Assistant Company Secretary of BAT. The report indicates that BAT has engaged in a transaction involving its own shares, details of which were made public and available by the company on July 8, 2024. The address of BAT's principal executive office is listed as Globe House, 4 Temple Place, London, United Kingdom.
英美菸草公司(BAT)是全球重要的國際菸草公司之一,於2024年7月8日向美國證券交易所(SEC)提交了6-k表格。該提交是美國外國私人發行人的要求,包括了日期爲同一日的所標題爲“自身股份的交易”的新聞發佈。該文件由BAt的高級助理公司秘書Nancy Jiang簽署。該報告顯示,BAt已經進行了涉及其自身股份的交易,並已於2024年7月8日公開披露和公開發布了有關細節。BAT首席執行官辦公地址爲倫敦廟廊4號地球大樓。
英美菸草公司(BAT)是全球重要的國際菸草公司之一,於2024年7月8日向美國證券交易所(SEC)提交了6-k表格。該提交是美國外國私人發行人的要求,包括了日期爲同一日的所標題爲“自身股份的交易”的新聞發佈。該文件由BAt的高級助理公司秘書Nancy Jiang簽署。該報告顯示,BAt已經進行了涉及其自身股份的交易,並已於2024年7月8日公開披露和公開發布了有關細節。BAT首席執行官辦公地址爲倫敦廟廊4號地球大樓。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息